Oct 9 (Reuters) - Akero Therapeutics Inc ( AKRO ): * AKERO THERAPEUTICS TO BE ACQUIRED BY NOVO NORDISK FOR UP TO $5.2 BILLION * AKERO THERAPEUTICS INC ( AKRO ) - SHAREHOLDERS TO RECEIVE $54 PER SHARE IN CASH * AKERO THERAPEUTICS INC ( AKRO ) - SHAREHOLDERS TO RECEIVE $54 PER SHARE IN CASH AND CVR OF $6...

STOCKHOLM (Reuters) -Novo Nordisk said on Thursday it had agreed to buy Akero Therapeutics ( AKRO ) for up to $5.2 billion, giving the Danish drugmaker access to the U.S.-based company's experimental liver disease drug. The maker of blockbuster obesity drug Wegovy is pressing ahead with a sweeping restructuring in a bid to revive sales growth and fend off intense...

06:19 AM EDT, 10/09/2025 (MT Newswires) -- PepsiCo ( PEP ) reported fiscal Q3 core earnings Thursday of $2.29 per diluted share, down from $2.31 a year earlier. Analysts polled by FactSet expected $2.26. Revenue for the quarter ended Sept. 6 was $23.94 billion, up from $23.32 billion a year earlier. Analysts surveyed by FactSet expected $23.83 billion. ...

06:19 AM EDT, 10/09/2025 (MT Newswires) -- Microsoft ( MSFT ) has signed a licensing agreement with Harvard University's graduate medical school to gain access to the department's consumer health content, multiple news outlets reported Wednesday. Reuters reported that Harvard University has announced the agreement, saying it was made through Harvard Health Publishing and that Microsoft ( MSFT ) has...